A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

Clinical trial NCT06873555 · RECRUITING

Trial details

NCT number: NCT06873555
Sponsor: Heronova Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Ovarian Cancer Small Cell Lung Cancer

Start date: 2024-09-11
Primary completion: 2026-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.